The position and importance of pharmacy in the innovative economy – the world, Europe, and Poland. Active substances – the faces of medicines safety and health safety during the pandemic and beyond. The manufacture of medicines versus disrupted supply chains. Key conditions for investment development and scientific and research activity in the pharmaceutical industry. FENG – European Funds for a Modern Economy – one of the major programmes financed under the new cohesion policy for 2021–2027. The objectives and available measures. Potential beneficiaries of the FENG in the pharmaceutical sector – the role of co-operation with science. Polish medicine manufacturers on the global pharmaceutical map – today and tomorrow.
Member of the Polish Parliament (Sejm); Chairman, Parliamentary Group for Medicines Autonomy, Polish Parliament (Sejm)
Public Affairs and Market Access Director, Adamed Pharma SA
Vice-President for Research Funding, Medical Research Agency
President of the Board, Polish Association of Pharmaceutical Industry Employers – Medicines for Poland (Polski Związek Pracodawców Przemysłu Farmaceutycznego – Krajowi Producenci Leków)
Polpharma Group
Director of the Department for Innovation and Development Programs, Ministry of Development Funds and Regional Policy
National Industrial Pharmacy Consultant; Head, Department of Applied Pharmacy, Faculty of Pharmacy, Medical University of Gdańsk
deputy director, Department of Innovation and Industrial Policy, Ministry of Economic Development, Labour and Technology
You watching archival version of European Economic Congress
What you can do:
Go to the current edition page or Continue browsing
The 2027 edition of the European Economic Congress will take place between April 19th and 23rd and, as always, will last for three days.
The exact date will be announced this year.